The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

SUMMARY: The FREEDOM study and its Extension provide long-term information about the effects of denosumab for the treatment of postmenopausal osteoporosis. Treatment for up to 8 years was associated with persistent reduction of bone turnover, continued increases in bone mineral density, low fracture...

Descripción completa

Detalles Bibliográficos
Autores principales: Papapoulos, S., Lippuner, K., Roux, C., Lin, C. J. F., Kendler, D. L., Lewiecki, E. M., Brandi, M. L., Czerwiński, E., Franek, E., Lakatos, P., Mautalen, C., Minisola, S., Reginster, J. Y., Jensen, S., Daizadeh, N. S., Wang, A., Gavin, M., Libanati, C., Wagman, R. B., Bone, H. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656716/
https://www.ncbi.nlm.nih.gov/pubmed/26202488
http://dx.doi.org/10.1007/s00198-015-3234-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656716/
https://www.ncbi.nlm.nih.gov/pubmed/26202488
http://dx.doi.org/10.1007/s00198-015-3234-7

Ejemplares similares